Antiandrogen monotherapy in patients with localized or locally advanced prostate cancer: final results from the bicalutamide Early Prostate Cancer programme at a median follow-up of 9.7 years-Reference-Cited by-同舟云学术

Antiandrogen monotherapy in patients with localized or locally advanced prostate cancer: final results from the bicalutamide Early Prostate Cancer programme at a median follow-up of 9.7 years

Published:2010-04 Issue:8 Volume:105 Page:1074-1081
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:

Author:

Iversen Peter,McLeod David G.,See William A.,Morris Thomas,Armstrong Jon,Wirth Manfred P.,

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1464-410X.2010.09319.x/fullpdf

Reference25 articles.

1. Guideline for the management of clinically localized prostate cancer: 2007 update;Thompson;J Urol,2008

2. EAU guidelines on prostate cancer;Heidenreich;Eur Urol,2008

3. Immediate versus deferred treatment for advanced prostatic cancer: initial results of the Medical Research Council Trial. The Medical Research Council Prostate Cancer Working Party Investigators Group;The Medical Research Council Prostate Cancer Working Party Investigators Group;Br J Urol,1997

4. Management of locally advanced prostate cancer: a European consensus;Boccon-Gibod;Int J Clin Pract,2003

5. Use of additional treatment for prostate cancer after radical prostatectomy, radiation therapy, androgen deprivation, or watchful waiting;Berge;Scand J Urol Nephrol,2007

Cited by 102 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bothersome Hot Flashes Following Neoadjuvant Androgen Deprivation Therapy and Stereotactic Body Radiotherapy for Localized Prostate Cancer;Cureus;2024-03-07

2. Unveiling a pH-Responsive Dual-Androgen-Blocking Magnetic Molecularly Imprinted Polymer for Enhanced Synergistic Therapy of Prostate Cancer;ACS Applied Materials & Interfaces;2024-01-22

3. Novel Approaches in the Systemic Management of High-Risk Prostate Cancer;Clinical Genitourinary Cancer;2023-12

4. Effect of docetaxel added to bicalutamide in Hormone-Naïve non-metastatic prostate cancer with rising PSA, a randomized clinical trial (SPCG-14);Acta Oncologica;2023-04-03

5. Validity and Future of Primary Androgen Deprivation Therapy in Prostate Cancer. Integration in the Era of New Agents Targeting the Androgen Receptor;Archivos Españoles de Urología;2023